BioSpace News Archive

Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) President & CEO Joseph Moscato offers an open letter to shareholders to provide an update on the company’s response, operationally and scientifically. Dear Generex Shareholders, The emergence and rapid escalation of the COVID-19 pandemic has deeply impacted our lives as we never could have imagined. During these uncertain tim

ESAC, Inc. is pleased to announce the successful launch of the Proteomic Data Commons (PDC) within the National Cancer Institute’s (NCI) Cancer Research Data Commons (CRDC) on the cancer.gov domain on March 23, 2020.

Successfully obtained clones for all three selected Coronavirus Antigens

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has been granted two additional Breakthrough Device designations by the U.S. Food and Drug Administration (FDA) for the Merit WRAPSODY™ Endovascular Stent Graft System.

Grifols, S.A. announced that it has filed its 2019 Annual Report on Form 20-F with the United States Securities and Exchange Commission on April 6, 2020.

Surrozen Inc. announced that one of its scientific founders, Dr. Roel Nusse, received the 2020 Canada Gairdner International Award for Biomedical Research for pioneering work on the Wnt signaling pathway and its importance in development, cancer and stem cells.

Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ Reagent Rental (HSRR) program.

Metropolitan Dermatology, a leading dermatology practice with locations throughout New Jersey and New York, is expanding patient services to include telemedicine as a solution to these trying times.

Cell Types and MindScope research programs to enter new stages of resource generation and discovery; another neuroscience division to launch in 2022

Immunomedics Conference call and webcast today at 8:00 a.m. Eastern Time